Kaken Pharmaceutical Co (TSE:4521) Days Sales Outstanding : 119.65 (As of Dec. 2023)

View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Days Sales Outstanding?

Kaken Pharmaceutical Co's average Accounts Receivable for the three months ended in Dec. 2023 was 円24,276 Mil. Kaken Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was 円18,514 Mil. Hence, Kaken Pharmaceutical Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 119.65.

The historical rank and industry rank for Kaken Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

TSE:4521' s Days Sales Outstanding Range Over the Past 10 Years
Min: 97.04 Med: 104.04 Max: 123.37
Current: 114.74

During the past 13 years, Kaken Pharmaceutical Co's highest Days Sales Outstanding was 123.37. The lowest was 97.04. And the median was 104.04.

TSE:4521's Days Sales Outstanding is ranked worse than
80.32% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 72.57 vs TSE:4521: 114.74

Kaken Pharmaceutical Co's Days Sales Outstanding increased from Dec. 2022 (111.62) to Dec. 2023 (119.65).

Kaken Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Kaken Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Days Sales Outstanding Chart

Kaken Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

123.37

106.64

103.08

97.95

98.84

Kaken Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															111.62	116.89	99.12	111.81	119.65

Competitive Comparison of Kaken Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Kaken Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kaken Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaken Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Kaken Pharmaceutical Co's Days Sales Outstanding falls into.

Kaken Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Kaken Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (20260	+	19268)	/	2 )	/	72984	*	365
=	19764					/	72984	*	365
=	98.84

Kaken Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (23998	+	24554)	/	2 )	/	18514	*	365 / 4
=	24276					/	18514	*	365 / 4
=	119.65

Kaken Pharmaceutical Co (TSE:4521) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Kaken Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Kaken Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Kaken Pharmaceutical Co (TSE:4521) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

KKPCF:USA

Address

28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650

Website

http://www.kaken.co.jp

Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co (TSE:4521) Headlines

No Headlines